Kintegral Advisory LLC Has $637,000 Stake in Mettler-Toledo International, Inc. (NYSE:MTD)

Kintegral Advisory LLC reduced its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 33.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 539 shares of the medical instruments supplier's stock after selling 266 shares during the period. Kintegral Advisory LLC's holdings in Mettler-Toledo International were worth $637,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in MTD. SBI Securities Co. Ltd. bought a new position in shares of Mettler-Toledo International in the fourth quarter worth about $33,000. Edmond DE Rothschild Holding S.A. acquired a new position in Mettler-Toledo International during the fourth quarter valued at approximately $44,000. Golden State Wealth Management LLC grew its holdings in Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after purchasing an additional 35 shares during the period. Menard Financial Group LLC acquired a new position in Mettler-Toledo International during the fourth quarter valued at approximately $67,000. Finally, Blue Trust Inc. grew its holdings in Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after purchasing an additional 52 shares during the period. 95.07% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on MTD. Wells Fargo & Company lifted their price target on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Citigroup raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a research note on Monday, April 7th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price target for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price objective for the stock from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Finally, Robert W. Baird cut their price objective on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. Eight research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $1,300.36.

Mettler-Toledo International Trading Up 0.3%

Shares of NYSE:MTD traded up $3.43 on Friday, hitting $1,209.08. The company had a trading volume of 41,859 shares, compared to its average volume of 150,239. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,546.93. The stock has a market cap of $25.12 billion, a price-to-earnings ratio of 30.15, a P/E/G ratio of 3.72 and a beta of 1.37. The stock has a 50 day moving average price of $1,150.84 and a 200 day moving average price of $1,195.89.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The firm had revenue of $883.74 million during the quarter, compared to the consensus estimate of $876.61 million. During the same quarter in the previous year, the firm posted $8.89 EPS. The business's revenue for the quarter was down 4.6% compared to the same quarter last year. Sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director directly owned 120 shares in the company, valued at $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.77% of the stock is currently owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.